A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic.

For the first time in a decade, the American Heart Association and American Stroke Association issued new recommendations for preventing strokes.

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can still help people lose weight with fewer side effects at a lower cost.

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.

While Ozempic’s weight loss benefits are widely touted, the conversation is increasingly shifting toward its side effects. Commonly reported issues include: nausea, constipation and “Ozempic face,” a condition where rapid weight loss leads to a gaunt appearance.

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and those who can afford to buy them. Drugs like Ozempic, which isn’t available in New Zealand,